CIA
ONCY

Concurrent Investment Advisors’s Oncolytics Biotech ONCY Stock Holding History

Concurrent Investment Advisors’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.9K Buy
+12,500
New +$11.6K ﹤0.01% 2092

Other funds holding ONCY

IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
BPWM
Badgley Phelps Wealth Managers Seattle, Washington $5.71B AUM 30.33% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PAS
Professional Advisory Services Vero Beach, Florida $836M AUM 25.79% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Concurrent Investment Advisors's ONCY Position: Q2 2026 in Review

Concurrent Investment Advisors opened a new position in Oncolytics Biotech (ONCY) in Q2 2026: 12,500 shares worth $11.9K. The stake represents ﹤0.01% of the portfolio and ranks #2092 among its holdings.

24 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

  • Concurrent Investment Advisors held 12,500 shares of Oncolytics Biotech worth $11.9K as of Q2 2026.
  • Oncolytics Biotech was a new Concurrent Investment Advisors position in Q2 2026.
  • Oncolytics Biotech made up ﹤0.01% of Concurrent Investment Advisors's portfolio in Q2 2026, its #2092 holding.
  • 24 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.